FR2346353B1 - - Google Patents

Info

Publication number
FR2346353B1
FR2346353B1 FR7709680A FR7709680A FR2346353B1 FR 2346353 B1 FR2346353 B1 FR 2346353B1 FR 7709680 A FR7709680 A FR 7709680A FR 7709680 A FR7709680 A FR 7709680A FR 2346353 B1 FR2346353 B1 FR 2346353B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7709680A
Other languages
French (fr)
Other versions
FR2346353A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cooper Laboratories Inc
Original Assignee
Cooper Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/672,437 external-priority patent/US4089959A/en
Priority claimed from US05/672,388 external-priority patent/US4120947A/en
Application filed by Cooper Laboratories Inc filed Critical Cooper Laboratories Inc
Publication of FR2346353A1 publication Critical patent/FR2346353A1/en
Application granted granted Critical
Publication of FR2346353B1 publication Critical patent/FR2346353B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
FR7709680A 1976-03-31 1977-03-31 XANTHIN COMPOUNDS AND METHODS FOR TREATING BRONCHOSPASTIC AND ALLERGIC DISEASES Granted FR2346353A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/672,437 US4089959A (en) 1976-03-31 1976-03-31 Long-acting xanthine bronchodilators and antiallergy agents
US05/672,388 US4120947A (en) 1976-03-31 1976-03-31 Xanthine compounds and method of treating bronchospastic and allergic diseases

Publications (2)

Publication Number Publication Date
FR2346353A1 FR2346353A1 (en) 1977-10-28
FR2346353B1 true FR2346353B1 (en) 1980-03-07

Family

ID=27100746

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7709680A Granted FR2346353A1 (en) 1976-03-31 1977-03-31 XANTHIN COMPOUNDS AND METHODS FOR TREATING BRONCHOSPASTIC AND ALLERGIC DISEASES

Country Status (5)

Country Link
JP (1) JPS52122396A (en)
CA (1) CA1077932A (en)
DE (1) DE2713389A1 (en)
FR (1) FR2346353A1 (en)
GB (1) GB1561005A (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416810C (en) * 1977-10-14 1982-05-11 Draco Ab PROCEDURE FOR THE PREPARATION OF Xanthine DERIVATIVES WITH ANTIALLERGIC ACTIVITY
SE7810947L (en) * 1978-10-20 1980-04-21 Draco Ab 3-ALKYLXANTHINES
SE7810946L (en) * 1978-10-20 1980-04-21 Draco Ab METHOD OF TREATING CHRONIC OBSTRUCTIVE AIR DISEASE
SE8002910L (en) * 1980-04-18 1981-10-19 Draco Ab 3,8-DIALKYLXANTINES, PROCEDURES FOR THEIR PREPARATION, PREPARATION AND METHODS OF TREATMENT OF CHRONIC OBSTRUCTIVE AIR DISORDER AND CARDIOVASCULAR DISEASES
CH643260A5 (en) * 1980-05-02 1984-05-30 Nestle Sa 1-ALLYL-3-BUTYL-8-METHYLXANTHINE, METHOD OF PREPARATION AND USE IN A MEDICAMENT.
FR2611716A1 (en) * 1987-03-06 1988-09-09 Uriach Cia Sa J Diisobutylxanthine derivatives substituted in position 7 which are useful as bronchodilators, process for their preparation and pharmaceutical composition containing them
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
IT1229195B (en) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa XANTHINIC DERIVATIVES WITH BRONCODILATORY ACTIVITY AND THEIR THERAPEUTIC APPLICATIONS.
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
AU4527996A (en) 1994-12-13 1996-07-03 Euro-Celtique S.A. Trisubstituted thioxanthines
EP0814809B1 (en) * 1994-12-13 2003-08-13 Euroceltique S.A. Aryl thioxanthines
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2729643A (en) * 1956-01-03 J-disubstmjied and i

Also Published As

Publication number Publication date
JPS5720313B2 (en) 1982-04-27
GB1561005A (en) 1980-02-13
FR2346353A1 (en) 1977-10-28
CA1077932A (en) 1980-05-20
DE2713389A1 (en) 1977-10-13
JPS52122396A (en) 1977-10-14
DE2713389C2 (en) 1992-03-19

Similar Documents

Publication Publication Date Title
DE2703373C2 (en)
FR2346353B1 (en)
DE2656160C2 (en)
JPS561552Y2 (en)
DE2634582C3 (en)
JPS5326127U (en)
DE2649125C2 (en)
FR2341775B3 (en)
JPS5373654U (en)
JPS5717499Y2 (en)
DE2606608A1 (en)
JPS5349064U (en)
JPS5345450U (en)
JPS535373U (en)
JPS5325669U (en)
JPS52154193U (en)
JPS52145603U (en)
JPS52108650U (en)
CS178389B1 (en)
DD125093A5 (en)
CH598994A5 (en)
DD123805A1 (en)
CH594305A5 (en)
DD123808A1 (en)
DD127018A1 (en)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse